Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ames

Showing results (381-390 of 416) with videos related to

Pageof 42
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15Christine M Freeman, MeiLan K Han, Fernando J Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2012
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8Matthew P Goetz, Vera J Suman, Tanya L Hoskin, et al.
Aging|January 8, 2020
Network analysis of human muscle adaptation to aging and contractionCraig R G Willis, Ryan M Ames, Colleen S Deane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemiaScott H Kaufmann, Judith E Karp, Louis Letendre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trialsMatthew P Goetz, Daniel J Schaid, D Lawrence Wickerham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end pointsKeith C Bible, Janet L Lensing, Sacha A Nelson, et al.
Toxicology Letters|September 3, 2025
Establishing scientific confidence in a two-chamber co-culture system to evaluate androgenic response in the presence of hepatic metabolismTessa C A van Tongeren, Susan J Hall, Samantha J Madnick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistanceMatthew P Goetz, Vera J Suman, Fergus J Couch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2Beata Holkova, Jeffrey G Supko, Matthew M Ames, et al.
Pageof 42

Showing results (381-390 of 416) with videos related to

Sort By:
Pageof 42
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15Christine M Freeman, MeiLan K Han, Fernando J Martinez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2012
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8Matthew P Goetz, Vera J Suman, Tanya L Hoskin, et al.
Aging|January 8, 2020
Network analysis of human muscle adaptation to aging and contractionCraig R G Willis, Ryan M Ames, Colleen S Deane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemiaScott H Kaufmann, Judith E Karp, Louis Letendre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trialsMatthew P Goetz, Daniel J Schaid, D Lawrence Wickerham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end pointsKeith C Bible, Janet L Lensing, Sacha A Nelson, et al.
Toxicology Letters|September 3, 2025
Establishing scientific confidence in a two-chamber co-culture system to evaluate androgenic response in the presence of hepatic metabolismTessa C A van Tongeren, Susan J Hall, Samantha J Madnick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistanceMatthew P Goetz, Vera J Suman, Fergus J Couch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2Beata Holkova, Jeffrey G Supko, Matthew M Ames, et al.
Pageof 42